Fineline Cube

Follow:
14486 Articles
NMPA Releases 96th Reference Listed Drugs Catalog, Adding 42 New Generic Specifications
Policy / Regulatory

NMPA Releases 96th Reference Listed Drugs Catalog, Adding 42 New Generic Specifications

CSPC Pharmaceutical Group Submits Anbenitamab for NMPA Approval in HER2‑Positive Gastric Cancer
CompanyDrug

CSPC Pharmaceutical Group Submits Anbenitamab for NMPA Approval in HER2‑Positive Gastric Cancer

BioNTech and BMS Reveal Promising Interim Results for Pumitamig in ES‑SCLC
CompanyDrug

BioNTech and BMS Reveal Promising Interim Results for Pumitamig in ES‑SCLC

Summit Therapeutics Presents 2025 HARMONi Study Results at World Lung Cancer Conference
CompanyDrug

Summit Therapeutics Presents 2025 HARMONi Study Results at World Lung Cancer Conference

Guangzhou’s Bio‑Thera Solutions Secures $5.4 Million Milestone from Intas Pharma
Company

Guangzhou’s Bio‑Thera Solutions Secures $5.4 Million Milestone from Intas Pharma

FDA Launches Aggressive Campaign to Curb Misleading Drug Advertisements
CompanyPolicy / Regulatory

FDA Launches Aggressive Campaign to Curb Misleading Drug Advertisements

MSD scrapes £1 billion UK expansion, shifts life‑science research to the US
Company

MSD scrapes £1 billion UK expansion, shifts life‑science research to the US

FibroX Therapeutics Secures IND Approval for FibroCell in Lumbar Disc Degeneration
CompanyDrug

FibroX Therapeutics Secures IND Approval for FibroCell in Lumbar Disc Degeneration

NMPA Unveils 30‑Working‑Day Pathway to Accelerate Innovative Drug Trials
DrugPolicy / Regulatory

NMPA Unveils 30‑Working‑Day Pathway to Accelerate Innovative Drug Trials

Genrix Bio Secures NMPA Approval for GR1803 Bispecific Antibody in Systemic Lupus Erythematosus
CompanyDrug

Genrix Bio Secures NMPA Approval for GR1803 Bispecific Antibody in Systemic Lupus Erythematosus

GenFleet Therapeutics Surges onto Hong Kong Main Board, Raising HK$1.58 B
CompanyDeals

GenFleet Therapeutics Surges onto Hong Kong Main Board, Raising HK$1.58 B

Remedium Bio Teams Up With Eli Lilly to Push Gene‑Therapy Frontiers for Diabetes and Obesity
CompanyDeals

Remedium Bio Teams Up With Eli Lilly to Push Gene‑Therapy Frontiers for Diabetes and Obesity